Brian M Culley is President and CEO of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 194,842 shares of LCTX, which is worth approximately $97,421. The most recent transaction as insider was on Nov 21, 2024, when has been sold 40,000 shares (Common Shares) at a price of $0.6 per share, resulting in proceeds of $24,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 195K
25.83% 3M change
54.15% 12M change
Total Value Held $97,421

Brian M Culley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2024
BUY
Open market or private purchase
$24,000 $0.6 p/Share
40,000 Added 17.03%
194,842 Common Shares
May 24 2024
BUY
Open market or private purchase
$10,500 $1.05 p/Share
10,000 Added 6.07%
154,842 Common Shares
Feb 11 2024
SELL
Payment of exercise price or tax liability
$13,830 $1.08 p/Share
12,806 Reduced 8.12%
144,842 Common Shares, no par ...
Feb 11 2024
BUY
Exercise of conversion of derivative security
-
31,249 Added 16.54%
157,648 Common Shares, no par ...
Feb 11 2023
SELL
Payment of exercise price or tax liability
$17,204 $1.35 p/Share
12,744 Reduced 9.16%
126,399 Common Shares, no par ...
Feb 11 2023
BUY
Exercise of conversion of derivative security
-
31,249 Added 18.34%
139,143 Common Shares, no par ...
Jun 30 2022
SELL
Payment of exercise price or tax liability
$8,442 $1.58 p/Share
5,343 Reduced 4.72%
107,894 Common Shares, no par ...
Jun 30 2022
BUY
Exercise of conversion of derivative security
-
15,450 Added 12.01%
113,237 Common Shares, no par ...
Mar 31 2022
SELL
Payment of exercise price or tax liability
$8,228 $1.54 p/Share
5,343 Reduced 5.52%
91,387 Common Shares, no par ...
Mar 31 2022
BUY
Exercise of conversion of derivative security
-
15,450 Added 13.77%
96,730 Common Shares, no par ...
Mar 31 2022
BUY
Open market or private purchase
$9,792 $1.53 p/Share
6,400 Added 6.14%
97,787 Common Shares, no par ...
Mar 25 2022
BUY
Open market or private purchase
$7,245 $1.38 p/Share
5,250 Added 6.07%
81,280 Common Shares, no par ...
Dec 31 2021
SELL
Payment of exercise price or tax liability
$13,090 $2.45 p/Share
5,343 Reduced 6.57%
76,030 Common Shares, no par ...
Dec 31 2021
BUY
Exercise of conversion of derivative security
-
15,450 Added 15.96%
81,373 Common Shares, no par ...
Sep 30 2021
SELL
Payment of exercise price or tax liability
$13,464 $2.52 p/Share
5,343 Reduced 7.5%
65,923 Common Shares, no par ...
Sep 30 2021
BUY
Exercise of conversion of derivative security
-
15,450 Added 17.82%
71,266 Common Shares, no par ...
Jun 30 2021
SELL
Payment of exercise price or tax liability
$15,228 $2.85 p/Share
5,343 Reduced 8.74%
55,816 Common Shares, no par ...
Jun 30 2021
BUY
Exercise of conversion of derivative security
$44,032 $2.85 p/Share
15,450 Added 20.17%
61,159 Common Shares, no par ...
Jun 28 2021
SELL
Open market or private sale
$1,291,500 $2.87 p/Share
450,000 Reduced 90.78%
45,709 Common Shares, no par ...
Jun 28 2021
BUY
Exercise of conversion of derivative security
$207,000 $0.69 p/Share
300,000 Added 37.7%
495,709 Common Shares, no par ...
Mar 31 2021
SELL
Payment of exercise price or tax liability
$12,556 $2.35 p/Share
5,343 Reduced 2.66%
195,709 Common Shares, no par ...
Mar 31 2021
BUY
Exercise of conversion of derivative security
$36,307 $2.35 p/Share
15,450 Added 7.14%
201,052 Common Shares, no par ...
Dec 31 2020
SELL
Payment of exercise price or tax liability
$9,404 $1.76 p/Share
5,343 Reduced 2.8%
185,602 Common Shares, no par ...
Dec 31 2020
BUY
Exercise of conversion of derivative security
$27,192 $1.76 p/Share
15,450 Added 7.49%
190,945 Common Shares, no par ...
Sep 30 2020
SELL
Payment of exercise price or tax liability
$5,022 $0.94 p/Share
5,343 Reduced 2.95%
175,495 Common Shares, no par ...
BMC

Brian M Culley

President and CEO
Carlsbad, CA

Track Institutional and Insider Activities on LCTX

Follow Lineage Cell Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

News

Receive news related to Lineage Cell Therapeutics, Inc.

Track Activities on LCTX